Study: Targeted drug combos block tumor cell growth

09/13/2007 | ScientificAmerican.com

A combination of targeted cancer drugs, also known as receptor tyrosine kinases, can outsmart tumor cells by preventing protein switches from inciting cell growth, U.S. researchers report. However, scientists said further studies are needed before the combination treatments can be recommended to cancer patients, given the drugs' possible toxicity risk and high cost.

View Full Article in:

ScientificAmerican.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ
RN Care Manager
MJHS
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC